Loring Wolcott & Coolidge Fiduciary Advisors LLP Abbott Laboratories Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.9 Billion
- Q4 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,723,720 shares of ABT stock, worth $221 Million. This represents 1.79% of its overall portfolio holdings.
Number of Shares
1,723,720
Previous 1,729,778
0.35%
Holding current value
$221 Million
Previous $197 Million
1.14%
% of portfolio
1.79%
Previous 1.78%
Shares
33 transactions
Others Institutions Holding ABT
# of Institutions
3,228Shares Held
1.3BCall Options Held
8.71MPut Options Held
8.03M-
Vanguard Group Inc Valley Forge, PA168MShares$21.6 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.85 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.44 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.85 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $225B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...